List of Contents

Paper Diagnostics Market Size, Share, and Trends 2024 to 2034

The global paper diagnostics market size is calculated at USD 17.43 billion in 2024, grew to USD 18.51 billion in 2025, and is predicted to hit around USD 31.80 billion by 2034, poised to grow at a CAGR of 6.2% between 2024 and 2034. The North America paper diagnostics market size accounted for USD 6.62 billion in 2024 and is anticipated to grow at the fastest CAGR of 6.33% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 3651
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Paper Diagnostics Market 

5.1. COVID-19 Landscape: Paper Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Paper Diagnostics Market, By Kit Type

8.1. Paper Diagnostics Market Revenue and Volume Forecast, by Kit Type, 2024-2034

8.1.1. Lateral Flow Assays

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Paper Based Microfluidics

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Dipsticks

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Paper Diagnostics Market, By Device Type

9.1. Paper Diagnostics Market Revenue and Volume Forecast, by Device Type, 2024-2034

9.1.1. Diagnostic Devices

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Monitoring Devices

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Paper Diagnostics Market, By End-use 

10.1. Paper Diagnostics Market Revenue and Volume Forecast, by End-use, 2024-2034

10.1.1. Assisted Living Healthcare Facilities

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Hospital and Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Paper Diagnostics Market, By Application 

11.1. Paper Diagnostics Market Revenue and Volume Forecast, by Application, 2024-2034

11.1.1. Food Quality Testing

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Environmental Monitoring

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Clinical Diagnostics

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Paper Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.1.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.1.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.1.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.1.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.2.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.2.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.2.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.2.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.2.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.2.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.2.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.3.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.3.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.3.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.3.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.3.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.3.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.4.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.4.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.4.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.4.7.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.4.8.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.4.8.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.5.5.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Kit Type (2021-2034)

12.5.6.2. Market Revenue and Volume Forecast, by Device Type (2021-2034)

12.5.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

12.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

Chapter 13. Company Profiles

13.1. Abbott (Alere Inc.)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bio-Rad Laboratories, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Diagnostics for All, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Arkray, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Acon Laboratories, Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Ffei Life Science (Biognostix)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Kenosha Tapes

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Gvs S.P.A.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Micro Essential Laboratory Inc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Navigene

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client